Premium
Primary care diabetes prescribing rates: latest analysis shows continued rise in volume and cost
Author(s) -
Chaplin Steve
Publication year - 2017
Publication title -
practical diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.205
H-Index - 24
eISSN - 2047-2900
pISSN - 2047-2897
DOI - 10.1002/pdi.2075
Subject(s) - medicine , medical prescription , diabetes mellitus , primary care , family medicine , public health , health care , pediatrics , optometry , gerontology , nursing , endocrinology , economic growth , economics
30 PRACTICAL DIABETES VOL. 34 NO. 1 COPYRIGHT © 2017 JOHN WILEY & SONS The latest report on primary care prescribing for diabetes in England from NHS Digital (formerly from the Health and Social Care Information Centre) shows continued growth in prescribing volume and cost at a rate well in excess of that for all other medicines.1 In an in-depth analysis, Steve Chaplin here reports that, with support from management guidelines and emerging evidence, newer agents may after all reduce mortality, and there is clearly potential for an increase in prescribing for the foreseeable future.